Literature DB >> 18481073

Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.

Yasushi Nishihira1, Chun-Feng Tan, Osamu Onodera, Yasuko Toyoshima, Mitsunori Yamada, Takashi Morita, Masatoyo Nishizawa, Akiyoshi Kakita, Hitoshi Takahashi.   

Abstract

A nuclear protein, 43-kDa TAR DNA-binding protein (TDP-43), was recently identified as a component of the ubiquitinated inclusions (UIs) in frontotemporal lobar degeneration (FTLD-U) and sporadic amyotrophic lateral sclerosis (SALS). In the present study using immunohistochemistry, we examined various regions of the nervous system in a series of 35 SALS cases using a polyclonal antibody against TDP-43. Seven of the 35 cases had disease durations of more than 10 years with artificial respiratory support (ARS; duration: 69-156 months). In all cases, TDP-43-immunoreactive (ir) neuronal and glial cytoplasmic inclusions (NCIs and GCIs) were found together in many regions, including the histologically affected lower motor neuron nuclei. Cluster analysis of the distribution pattern of TDP-43-ir NCIs for cases without ARS (n = 28) identified two types (type 1, n = 16; type 2, n = 12). Type 2 was distinguished from type 1 by the presence of TDP-43-ir NCIs in the frontotemporal cortex, hippocampal formation, neostriatum and substantia nigra, and was significantly associated with dementia. Eleven of the 28 cases showed UIs in the hippocampal dentate granule cells, all of which had type-2 distribution pattern. Cases with ARS (n = 7) were also classified into the same types (type 1, n = 5; type 2, n = 2). Cases having type-1 distribution pattern (n = 21) showed no evident neuronal loss in most of the non-motor neuron nuclei where TDP-43-ir NCIs were present, whereas cases having type-2 distribution pattern (n = 14) often showed evident neuronal loss in the frontotemporal cortices, amygdaloid nuclei and substantia nigra. These findings indicate that SALS is a multisystem degenerative disease widely affecting both neurons and glial cells with a heterogeneous pattern of TDP-43-ir NCI distribution (SALS showing type-2 distribution pattern being closely linked to FTLD-U), and that long-term survival supported by a respirator has no apparent influence on the TDP-43 neuronal distribution pattern.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481073     DOI: 10.1007/s00401-008-0385-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  50 in total

1.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

2.  Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study.

Authors:  M Cirillo; F Esposito; G Tedeschi; G Caiazzo; A Sagnelli; G Piccirillo; R Conforti; F Tortora; M R Monsurrò; S Cirillo; F Trojsi
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

Review 3.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

4.  Prion-like disorders: blurring the divide between transmissibility and infectivity.

Authors:  Mimi Cushman; Brian S Johnson; Oliver D King; Aaron D Gitler; James Shorter
Journal:  J Cell Sci       Date:  2010-04-15       Impact factor: 5.285

5.  TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.

Authors:  Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2008-06-25       Impact factor: 17.088

Review 6.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

Review 7.  Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity.

Authors:  Dmitry Kryndushkin; Frank Shewmaker
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 8.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

9.  Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis.

Authors:  Daichi Yokoi; Naoki Atsuta; Hazuki Watanabe; Ryoichi Nakamura; Akihiro Hirakawa; Mizuki Ito; Hirohisa Watanabe; Masahisa Katsuno; Yuishin Izumi; Mitsuya Morita; Akira Taniguchi; Masaya Oda; Koji Abe; Kouichi Mizoguchi; Osamu Kano; Satoshi Kuwabara; Ryuji Kaji; Gen Sobue
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

Review 10.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.